224
Participants
Start Date
May 18, 2018
Primary Completion Date
July 8, 2021
Study Completion Date
July 8, 2021
AbbVie China /ID# 164373, Shanghai
Zhejiang Province People's Hospital /ID# 209342, Hangzhou
Sir Run Run Shaw Hospital /ID# 210820, Hangzhou
The First Hospital of Jiaxing /ID# 213686, Jiaxing
The Second Hospital of Jiaxing /ID# 210744, Jiaxing
Jinhua Municipal Central Hospital /ID# 209339, Jinhua
Shenzhen Futian Hospital for rheumatic Diseases /ID# 209340, Shenzhen
Sichuan Provincial orthopedic hospital /ID# 209341, Chengdu
West China Hospital, SCU West China School of Medicine, SCU /ID# 209333, Chengdu
The First affiliated hospital of chengdu medical university /ID# 210745, Chengdu
Lead Sponsor
AbbVie
INDUSTRY